Association between the tumour necrosis factor-α -308G/A polymorphism and chronic obstructive pulmonary disease: An update

Respirology

Volumn 16, Issue 1, 2011, Pages 107-115

  Zhang, Shihua ^a,b   Wang, Chunyu ^c   Xi, Bo ^d   Li, Xia ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HEILONGJIANG INSTITUTE OF TECHNOLOGY   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d SHANDONG UNIVERSITY   (China)

Author keywords

Chronic obstructive pulmonary disease; Cytokine; Inflammation; Lung; Tumour necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ASIAN; CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; PROMOTER REGION; RACE DIFFERENCE; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SYSTEMATIC REVIEW;

ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952275601     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2010.01879.x     Document Type: Review

References (74)

1. Rabe KF, Hurd S, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007; 176: 532-55. (Pubitemid 47403272)
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-504.
3. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364: 613-20. (Pubitemid 39094180)
4. Mannino DM. Chronic obstructive pulmonary disease: definition and epidemiology. Respir. Care 2003; 48: 1185-91; discussion 91-3.
5. Postma DS, Boezen HM. Rationale for the Dutch hypothesis. Allergy and airway hyperresponsiveness as genetic factors and their interaction with environment in the development of asthma and COPD. Chest 2004; 126: 96S-104S; discussion 59S-61S.
6. De Boer WI. Cytokines and therapy in COPD: a promising combination? Chest 2002; 121: 209S-18S.
7. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur. Respir. J. Suppl. 2001; 34: 50s-9s.
8. Chung KF. Cytokines as targets in chronic obstructive pulmonary disease. Curr. Drug Targets 2006; 7: 675-81. (Pubitemid 43827263)
9. Boezen HM. Genome-wide association studies: what do they teach us about asthma and chronic obstructive pulmonary disease? Proc. Am. Thorac. Soc. 2009; 6: 701-3.
10. Castaldi PJ, Cho MH, Cohn M et al. The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. Hum. Mol. Genet. 2010; 19: 526-34.
11. Silverman EK, Spira A, Pare PD. Genetics and genomics of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2009; 6: 539-42.
12. Bosse Y. Genetics of chronic obstructive pulmonary disease: a succinct review, future avenues and prospective clinical applications. Pharmacogenomics 2009; 10: 655-67.
13. Walter R, Gottlieb DJ, O'Connor GT. Environmental and genetic risk factors and gene-environment interactions in the pathogenesis of chronic obstructive lung disease. Environ. Health Perspect. 2000; 108 (Suppl. 4): 733-42.
14. Yanbaeva DG, Dentener MA, Creutzberg EC et al. Systemic inflammation in COPD: is genetic susceptibility a key factor? COPD 2006; 3: 51-61. (Pubitemid 43869516)
15. Sandford AJ, Silverman EK. Chronic obstructive pulmonary disease. 1: susceptibility factors for COPD the genotype-environment interaction. Thorax 2002; 57: 736-41. (Pubitemid 34864534)
16. Molfino NA. Genetics of COPD. Chest 2004; 125: 1929-40. (Pubitemid 38648430)
17. Joos L, Pare PD, Sandford AJ. Genetic risk factors of chronic obstructive pulmonary disease. Swiss Med. Wkly. 2002; 132: 27-37. (Pubitemid 34266546)
18. Sampsonas F, Karkoulias K, Kaparianos A et al. Genetics of chronic obstructive pulmonary disease, beyond alpha1-antitrypsin deficiency. Curr. Med. Chem. 2006; 13: 2857-73. (Pubitemid 44509712)
19. Zhernakova A, van Diemen CC, Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat. Rev. Genet. 2009; 10: 43-55.
20. Churg A, Dai J, Tai H et al. Tumor necrosis factor-alpha is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am. J. Respir. Crit. Care Med. 2002; 166: 849-54.
21. Lundblad LK, Thompson-Figueroa J, Leclair T et al. Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. Am. J. Respir. Crit. Care Med. 2005; 171: 1363-70. (Pubitemid 40800508)
22. Vuillemenot BR, Rodriguez JF, Hoyle GW. Lymphoid tissue and emphysema in the lungs of transgenic mice inducibly expressing tumor necrosis factor-alpha. Am. J. Respir. Cell Mol. Biol. 2004; 30: 438-48. (Pubitemid 38457177)
23. Churg A, Wang RD, Tai H et al. Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse. Am. J. Respir. Crit. Care Med. 2004; 170: 492-8. (Pubitemid 39209129)
24. Keatings VM, Collins PD, Scott DM et al. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am. J. Respir. Crit. Care Med. 1996; 153: 530-4.
25. Wilson AG, di Giovine FS, Blakemore AI et al. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum. Mol. Genet. 1992; 1: 353.
26. Louis E, Franchimont D, Piron A et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin. Exp. Immunol. 1998; 113: 401-6. (Pubitemid 28410565)
27. Wilson AG, Symons JA, McDowell TL et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA 1997; 94: 3195-9. (Pubitemid 27157287)
28. Braun N, Michel U, Ernst BP et al. Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production. Neurosci. Lett. 1996; 215: 75-8. (Pubitemid 26313221)
29. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol. Immunol. 1997; 34: 391-9. (Pubitemid 27368335)
30. Wu WS, McClain KL. DNA polymorphisms and mutations of the tumor necrosis factor-alpha (TNF-alpha) promoter in Langerhans cell histiocytosis (LCH). J. Interferon Cytokine Res. 1997; 17: 631-5. (Pubitemid 27451161)
31. Liu L, Zhuang W, Wang C et al. Interleukin-8 -251 A/T gene polymorphism and gastric cancer susceptibility: a meta-analysis of epidemiological studies. Cytokine 2010; 50: 328-34.
32. Wang R, Zhong B, Liu Y et al. Association between alpha-adducin gene polymorphism (Gly460Trp) and genetic predisposition to salt sensitivity: a meta-analysis. J. Appl. Genet. 2010; 51: 87-94.
33. Sun L, Xi B, Yu L et al. Association of glutathione S-transferases polymorphisms (GSTM1 and GSTT1) with senile cataract: a meta-analysis. Invest Ophthalmol Vis Sci. 2010. doi: 10.1167/iovs.10-5815.
34. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986; 7: 177-88. (Pubitemid 17189972)
35. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959; 22: 719-48.
36. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.
37. Egger M, Davey Smith G, Schneider M et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34. (Pubitemid 27387172)
38. Broekhuizen R, Grimble RF, Howell WM et al. Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1beta -511 single nucleotide polymorphism. Am. J. Clin. Nutr. 2005; 82: 1059-64. (Pubitemid 43779765)
39. Brogger J, Steen VM, Eiken HG et al. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. Eur. Respir. J. 2006; 27: 682-8. (Pubitemid 44914189)
40. Chappell S, Daly L, Morgan K et al. Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD. Eur. Respir. J. 2007; 30: 810-12.
41. Chen YC, Liu SF, Chin CH et al. Association of tumor necrosis factor-alpha-863C/A gene polymorphism with chronic obstructive pulmonary disease. Lung 2010; 188: 339-47.
42. Chierakul N, Wongwisutikul P, Vejbaesya S et al. Tumor necrosis factor-alpha gene promoter polymorphism is not associated with smoking-related COPD in Thailand. Respirology 2005; 10: 36-9. (Pubitemid 40343760)
43. Danilko KV, Korytina GF, Akhmidishina LZ et al. Association of cytokines genes (ILL, IL1RN, TNF, LTA, IL6, IL8, IL0) polymorphic markers with chronic obstructive pulmonary disease. Mol. Biol. (Mosk.) 2007; 41: 26-36.
44. Du Y, Sun HM, Li Y. The relationship between genetic polymorphism of tumor necrosis factor-alpha, human beta-defensin-1 and the development of chronic obstructive pulmonary disease. Clin. Med. J. China 2008; 15: 329-31 (in Chinese).
45. Ferrarotti I, Zorzetto M, Beccaria M et al. Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema. Eur. Respir. J. 2003; 21: 444-9. (Pubitemid 36342245)
46. Gingo MR, Silveira LJ, Miller YE et al. Tumour necrosis factor gene polymorphisms are associated with COPD. Eur. Respir. J. 2008; 31: 1005-12.
47. Gong Y, Jin ML, Ren T et al. Association of tumor necrosis factor gene promoter polymorphism with chronic obstructive pulmonary disease. Clin. Med. J. China 2008; 15: 166-9 (in Chinese).
48. Hegab AE, Sakamoto T, Saitoh W et al. Polymorphisms of TNFalpha, IL1beta, and IL1RN genes in chronic obstructive pulmonary disease. Biochem. Biophys. Res. Commun. 2005; 329: 1246-52. (Pubitemid 40568703)
49. Hersh CP, Demeo DL, Lange C et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am. J. Respir. Cell Mol. Biol. 2005; 33: 71-8. (Pubitemid 40961016)
50. Higham MA, Pride NB, Alikhan A et al. Tumour necrosis factoralpha gene promoter polymorphism in chronic obstructive pulmonary disease. Eur. Respir. J. 2000; 15: 281-4. (Pubitemid 30085953)
51. Hsieh MH, Chong IW, Hwang JJ et al. Lack of associations between several polymorphisms in cytokine genes and the risk of chronic obstructive pulmonary diseases in Taiwan. Kaohsiung J. Med. Sci. 2008; 24: 126-37.
52. Huang SL, Su CH, Chang SC. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am. J. Respir. Crit. Care Med. 1997; 156: 1436-9.
53. Ishii T, Matsuse T, Teramoto S et al. Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD. Respir. Med. 2000; 94: 847-51.
54. Jiang L, He B, Zhao MW et al. Association of gene polymorphisms of tumour necrosis factor-alpha and interleukin-13 with chronic obstructive pulmonary disease in Han nationality in Beijing. Chin. Med. J. (Engl) 2005; 118: 541-7. (Pubitemid 40515013)
55. Jiang P, Li Y. Association among genetic polymorphisms of HO-1, TNF-alpha and chronic obstructive pulmonary disease. J. Shandong Univ. (Health Sci.) 2006; 44: 1253-7 (in Chinese).
56. Keatings VM, Cave SJ, Henry MJ et al. A polymorphism in the tumor necrosis factor-alpha gene promoter region may predispose to a poor prognosis in COPD. Chest 2000; 118: 971-5.
57. Kucukaycan M, Van Krugten M, Pennings HJ et al. Tumor necrosis factor-alpha +489G/A gene polymorphism is associated with chronic obstructive pulmonary disease. Respir. Res. 2002; 3: 29.
58. Li Y, Du Y, Jiang P et al. Relationship of genetic polymorphisms of heme oxygenase-1, tumor necrosis factor-alpha, human beta-defensin-1 with chronic obstructive pulmonary disease. Chin. J. Geriatr. 2008; 27: 333-6 (in Chinese).
59. Ma ZM, Zhang ZX, Han ZM et al. A study on relationship between tumor necrosis factor alpha gene promoter polymorphism and susceptibility to development of COPD. Pract. Prev. Med. 2004; 11: 417-19 (in Chinese).
60. Papatheodorou A, Latsi P, Vrettou C et al. Development of a novel microarray methodology for the study of SNPs in the promoter region of the TNF-alpha gene: their association with obstructive pulmonary disease in Greek patients. Clin. Biochem. 2007; 40: 843-50. (Pubitemid 47077406)
61. Patuzzo C, Gile LS, Zorzetto M et al. Tumor necrosis factor gene complex in COPD and disseminated bronchiectasis. Chest 2000; 117: 1353-8. (Pubitemid 30321590)
62. Sakao S, Tatsumi K, Igari H et al. Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001; 163: 420-2. (Pubitemid 32158522)
63. Seifart C, Dempfle A, Plagens A et al. TNF-alpha-, TNF-beta-, IL-6-, and IL-10-promoter polymorphisms in patients with chronic obstructive pulmonary disease. Tissue Antigens 2005; 65: 93-100. (Pubitemid 40179668)
64. Shi YZ, Liu B, Zhang W et al. Study of the relationship between COPD and TNF-alpha gene polymorphism in Heilongjiang region. Chin. J. Tuberc. Respir. Dis. 2007; 30: 233-4 (in Chinese).
65. Shi YZ, Wang XJ, Sun HM et al. Detection of TNF-a gene polymorphism in COPD patients. Basic Med. Sci. Clin. 2000; 20: 95 (in Chinese).
66. Stankovic MM, Nestorovic AR, Tomovic AM et al. TNF-alpha-308 promotor polymorphism in patients with chronic obstructive pulmonary disease and lung cancer. Neoplasma 2009; 56: 348-52.
67. Tai Q, Xie CM. The relationship of tumor necrosis factor-alpha gene polymorphism with the susceptibility to chronic obstructive pulmonary disease in Han population of Guangzhou in China. Master Thesis, Zhongshan University, 2004; No. 20040520 (in Chinese).
68. Tang MQ, Mo HW, Cheng YQ. The relationship between the gene polymorphisms of TNF alpha and the genetic susceptibility to chronic obstructive pulmonary disease (COPD) with tuberculosis. J. Qiqihar Med. Coll. 2008; 29: 2949-51 (in Chinese).
69. Trajkov D, Mirkovska-Stojkovikj J, Petlichkovski A et al. Association of cytokine gene polymorphisms with chronic obstructive pulmonary disease in Macedonians. Iran. J. Allergy Asthma Immunol. 2009; 8: 31-42.
70. Yanbaeva DG, Korytina GF, Viktorova TV. Allelic variants of the tumor necrosis factor superfamily as markers of the severity of the course of chronic obstructive lung disease and bronchiectatic disease. Genetika 2004; 40: 545-51.
71. Zhang Y, Wang W, Xu SH et al. Association between polymorphism in the gene coding for tumor necrosis factor-alpha and chronic obstructive pulmonary disease. J. Taishan Med. Coll. 2007; 28: 106-9 (in Chinese).
72. Zhang YQ, Xiong JL. Correlation of genetic polymorphisms of TNF-alpha and chronic obstructive pulmonary disease in North Chinese Han people. Clin. Med. China 2008; 24: 129-30 (in Chinese).
73. Smolonska J, Wijmenga C, Postma DS et al. Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research. Am. J. Respir. Crit. Care Med. 2009; 180: 618-31.
74. Zhan P, Wang J, Wei SZ et al. TNF-308 gene polymorphism is associated with COPD risk among Asians: meta-analysis of data for 6,118 subjects. Mol. Biol. Rep. 2010; doi: 10.1007/s11033-010-0098-y.